<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    TransMedics Group, Inc.

    TransMedics Group, Inc.

    TransMedics is a commercial-stage medical technology company transforming organ tr...

    TransMedics is a commercial-stage medical techn...

    Filing Type:    PU
    Kodiak Sciences Inc

    Kodiak Sciences Inc

    Kodiak Sciences is a clinical stage company developing innovative therapeutics to ...

    Kodiak Sciences is a clinical stage company dev...

    Filing Type:    PU
    MISONIX, Inc.

    MISONIX, Inc.

    Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets ultrasoni...

    Misonix, Inc. (Nasdaq: MSON) designs, develops,...

    Filing Type:    PU
    Integra LifeSciences Holdings Corporation

    Integra LifeSciences Holdings Corporation

    Integra LifeSciences, a world leader in medical devices, is dedicated to limiting ...

    Integra LifeSciences, a world leader in medical...

    Filing Type:    PU
    Natus Medical Incorporated

    Natus Medical Incorporated

    Natus is a leading provider of healthcare products and services used for the scree...

    Natus is a leading provider of healthcare produ...

    Filing Type:    PU
    Phenomix Sciences LLC

    Phenomix Sciences LLC

    The objective of Phenomix Sciences, LLC (Phenomix) is to provide healthcare soluti...

    The objective of Phenomix Sciences, LLC (Phenom...

    Amount Raised:    $288,547.00
    Fundraising Status:    EC
    Filing Type:    CF
    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new...

    HOOKIPA Pharma Inc. is a clinical stage biophar...

    Filing Type:    PU
    Immuron Limited

    Immuron Limited

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...

    Immuron Ltd is a publicly listed Australian bio...

    Filing Type:    PU
    OncoSec Medical Incorporated

    OncoSec Medical Incorporated

    OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on ...

    OncoSec Medical Incorporated is a clinical-stag...

    Filing Type:    PU
    Vivos Inc

    Vivos Inc

    The Company is a radiation oncology medical device company engaged in the developm...

    The Company is a radiation oncology medical dev...

    Fundraising Status:    EC
    Filing Type:    RA
    Seattle Genetics, Inc.

    Seattle Genetics, Inc.

    Founded 20 years ago, Seattle Genetics was built on a foundation of scientific inn...

    Founded 20 years ago, Seattle Genetics was buil...

    Filing Type:    PU
    Merus N.V.

    Merus N.V.

    Merus is a clinical-stage immuno-oncology company developing innovative full-lengt...

    Merus is a clinical-stage immuno-oncology compa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.